References
- Sefton T. Getting less for more: economic evaluation in the social welfare field, (November). casepaper 44, Centre for analysis of social exclusion, London School of Economics. 2000
- Stolk EA, Busschbach JJ. Validity and feasibility of the use of condition-specific outcome measures in economic evaluation. Qual Life Res 2003;12(4):363-71
- Stolk EA, Oppe M, Scalone L, et al. Discrete choice modeling for the quantification of health states: the case of the EQ-5D. Value Health 2010;13(8):1005-13
- Ackaert S, Annemans L, De Smedt D, et al. Modelontwikkeling voor de economische evaluatie van welzijns- & gezondheidsprojecten en projectplannen (1ste druk) 2010
- Petersson C, Simeonsson RJ, Enskar K, et al. Comparing children’s self-report instruments for health-related quality of life using the international classification of functioning, disability and health for children and youth (ICF-CY). Health Qual Life Outcomes 2013;11:75
- Dodson JL, Furth SL, Hsiao CJ, et al. Health related quality of life in adolescents with abnormal bladder function: an assessment using the child health and illness profile-adolescent edition. J Urol 2008;180(4 Suppl):1846-51
- Brouwer WB, Koopmanschap MA, Rutten FF. Patient and informal caregiver time in cost-effectiveness analysis. Int J Technol Assess Health Care 1998;14(3):505-13
- Patel A, Knapp M, Evans A, et al. Training care givers of stroke patients: economic evaluation. BMJ 2004;328(7448):1102
- De Smedt D, Clays E, Annemans L, et al. EQ-5D versus SF-12 in coronary patients. Are they interchangeable? Value Health 2014;17(1):84-9
- McCollister KE, French MT. The relative contribution of outcome domains in the total economic benefit of addiction interventions: a review of first findings. Addiction 2003;98(12):1647-59
- Brazier J, Roberts J, Tsuchiya A, et al. A comparison of the EQ-5D and SF-36 across seven patient groups. Health Econ 2004;13(9):873-84
- Martinez-Martin P. An introduction to the concept of “quality of life in Parkinson’s disease”. J Neurol 1998;245(Suppl 1):S2-6
- Gómez-Gallego M, Gómez-Amor J, Gómez-García J. Determinants of quality of life in Alzheimer’s disease: perspective of patients, informal caregivers, and professional caregivers. Int Psychogeriatr 2012;24(11):1805-15
- Kim Y, Kim B, Chang JS, et al. Parental quality of life and depressive mood following methylphenidate treatment of children with attention-deficit hyperactivity disorder. Psychiatry Clin Neurosci 2014;68(7):506-14
- McDaid D. Estimating the costs of informal care for people with Alzheimer’s disease: methodological and practical challenges. Int J Geriatr Psychiatry 2001;16(4):400-5
- Hoefman RJ, van Exel NJ, Looren de Jong S, et al. A new test of the construct validity of the CarerQol instrument: measuring the impact of informal care giving. Qual Life Res 2011;20(6):875-87
- Deeken JF, Taylor KL, Mangan P, et al. Care for the caregivers: a review of self-report instruments developed to measure the burden, needs, and quality of life of informal caregivers. J Pain Symptom Manage 2003;26(4):922-53
- Brouwer WB, van Exel NJ, van Gorp B. The CarerQol instrument: a new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Qual Life Res 2006;15(6):1005-21
- Sales E. Family burden and quality of life. Qual Life Res 2003;12(Suppl 1):33-41
- Al-Janabi H, Coast J, Flynn TN. What do people value when they provide unpaid care for an older person? A meta-ethnography with interview follow-up. Soc Sci Med 2008;67(1):111-21
- Brouwer WB, van Exel NJ, van den Berg B. Process utility from providing informal care: the benefit of caring. Health Policy 2005;74(1):85-99
- Ruikes FG, Meys AR, van de Wetering G, et al. The CareWell-primary care program: design of a cluster controlled trial and process evaluation of a complex intervention targeting community-dwelling frail elderly. BMC Fam Pract 2012;13:115
- Van Eeden M, van Heugten CM, Evers SM. The economic impact of stroke in The Netherlands: the €-Restore4Stroke study. BMC Public Health 2012;12(1):122
- Birnbaum HG, White AG, Schiller M, et al. Original research article societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med 2011;12(1):657-67
- Weitzner MA, Jacobsen PB, Wagner H, et al. The Caregiver Quality of Life Index-Cancer (CQOLC) scale: development and validation of an instrument to measure quality of life of the family caregiver of patients with cancer. Qual Life Res 1999;8(1-2):55-63
- Andersson A, Levin LA, Emtinger BG. The economic burden of informal care. Int J Technol Assess Health Care 2002;18(1):46-54
- Ampt AJ, Amoroso C, Harris MF, et al. Attitudes, norms and controls influencing lifestyle risk factor management in general practice. BMC Fam Pract 2009;10:59
- Mission JF, Ohno MS, Cheng YW, et al. Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis. Am J Obstet Gynecol 2012;207(4):326
- Werner EF, Han CS, Pettker CM, et al. Universal cervical-length screening to prevent preterm birth: a cost-effectiveness analysis. Ultrasound Obstet Gynecol 2011;38(1):32-7
- Chung A, Macario A, El-Sayed YY, et al. Cost-effectiveness of a trial of labor after previous cesarean. Obstet Gynecol 2001;97(6):932-41
- Dismuke CE, French MT, Salomé HJ, et al. Out of touch or on the money: Do the clinical objectives of addiction treatment coincide with economic evaluation results? J Subst Abuse Treat 2004;27(3):253-63
- DeLeire T, Manning W. Labor market costs of illness: prevalence matters. Health Econ 2004;13(3):239-50
- Dijkgraaf MG, van der Zanden BP, de Borgie CA, et al. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. BMJ 2005;330(7503):1297
- Mark TL, Woody GE, Juday T, et al. The economic costs of heroin addiction in the United States. Drug Alcohol Depend 2001;61(2):195-206
- Stephen JH, Halpern CH, Barrios CJ, et al. Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: a threshold and cost-effectiveness analysis. Addiction 2012;107(3):624-34
- Strassels SA. Economic burden of prescription opioid misuse and abuse. J Manag Care Phar 2009;15(7):556-62
- Zarkin GA, Dunlap LJ, Hicks KA, et al. Benefits and costs of methadone treatment: results from a lifetime simulation model. Health Econ 2005;14(11):1133-50
- Byford S, Barrett B, Metribian N, et al. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction. Br J Psychiatry 2013;203:341-9
- Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the Economic Evaluation of Health Care Programmes. 3rd Edition. Oxford University Press 2005
- Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. Oxford University Press 1996
- Van den Berg B, Brouwer W, van Exel J, et al. Economic valuation of informal care: lessons from the application of the opportunity costs and proxy good methods. Soc Sci Med 2006;62(4):835-45
- Simoens S, Laekeman G. Applying health technology assessment to pharmaceutical care: pitfalls and future directions. Pharm World Sci 2005;27(2):73-5
- Beck RS, Daughtridge R, Sloane PD. Physician-patient communication in the primary care office: a systematic review. J Am Board Fam Pract 2000;15(1):25-38